Olivia C. Ware - 28 May 2024 Form 4 Insider Report for Arcellx, Inc. (ACLX)

Reporting relationship: Director
Issuer ticker: ACLX
Reported as of: 28 May 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Jun 2024, 16:18:55 UTC
Prior SEC filing: 29 May 2024
Next SEC filing: 06 Feb 2025
Source filing: View source filing
Reporting owner signature: /s/ Michelle Gilson, as Attorney-in-Fact

Key filing fact

Olivia C. Ware filed Form 4 for Arcellx, Inc. (ACLX) on 06 Jun 2024.

Key facts

This page summarizes Olivia C. Ware's Form 4 filing for Arcellx, Inc. (ACLX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 06 Jun 2024, 16:18.

Change

Previous filing in this sequence was filed on 29 May 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ACLX transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +8,011
Change %
Price: $0.000000
Shares after: 8,011
Date: 28 May 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,011
Exercise price: $51.30
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Subject to the reporting person's continuing to be a Service Provider (as defined in the 2022 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of May 28, 2025 or the next annual meeting of stockholders.